Speeding innovation for industry
Article | Diagnosis
Technologies for healthcare
The Clinatec research center brings together engineering and medicine in a whole new way, leveraging advances in micro and nanotechnology and electronics for safer, faster clinical proof-of-concept testing of innovative medical technologies. The center’s 80-person multidisciplinary research team is united in achieving a shared goal: to better prevent, diagnose, and treat neurodegenerative disease and cancer and offer enhanced quality of life to sufferers of significant motor handicaps.
The center is drawing on deep brain stimulation (DBS), a Parkinson’s treatment developed by Dr. Alim-Louis Benabid in the 1980s, to come up with an implantable device that would use light to stimulate the brains of Parkinson’s patients. Clinatec is also working on cancer, developing systems to safely explore damaged tissue and better identify biomarkers and targets for new cancer drugs. Finally, the center is striving to help tetraplegics regain the use of their limbs through brain-computer interfaces.
ALL TECHNOLOGY PLATFORMS
Researchers from CEA-Leti, a CEA Tech institute, tested a novel hypothermia treatment for glioblastoma, a particularly serious type of brain tumor, at biomedical research center Clinatec.
The degeneration of retinal ganglion cells, a type of neuron, is one of the main causes of blindness in the Western world. Researchers are exploring how optogenetics and electronics can be combined to compensate for malfunctioning retinal ganglion cells and restore a form of vision.
How to collaborate with CEA Tech teams ?
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.